HK1202881A1 - Process for enriching iga iga - Google Patents

Process for enriching iga iga

Info

Publication number
HK1202881A1
HK1202881A1 HK15103456.4A HK15103456A HK1202881A1 HK 1202881 A1 HK1202881 A1 HK 1202881A1 HK 15103456 A HK15103456 A HK 15103456A HK 1202881 A1 HK1202881 A1 HK 1202881A1
Authority
HK
Hong Kong
Prior art keywords
iga
enriching
enriching iga
iga iga
Prior art date
Application number
HK15103456.4A
Other languages
English (en)
Chinese (zh)
Inventor
Menyawi Ibrahim El
Marius Loetscher
Doreen Siegemund
Original Assignee
Csl Behring Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Behring Ag filed Critical Csl Behring Ag
Publication of HK1202881A1 publication Critical patent/HK1202881A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
HK15103456.4A 2012-03-09 2015-04-08 Process for enriching iga iga HK1202881A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12158927.9A EP2636681A1 (en) 2012-03-09 2012-03-09 Process for enriching IgA
PCT/EP2013/054698 WO2013132053A1 (en) 2012-03-09 2013-03-08 Process for enriching iga

Publications (1)

Publication Number Publication Date
HK1202881A1 true HK1202881A1 (en) 2015-10-09

Family

ID=47843296

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103456.4A HK1202881A1 (en) 2012-03-09 2015-04-08 Process for enriching iga iga

Country Status (10)

Country Link
US (1) US9828418B2 (xx)
EP (2) EP2636681A1 (xx)
JP (1) JP6259777B2 (xx)
KR (1) KR102079487B1 (xx)
CN (1) CN104245728B (xx)
AU (1) AU2013201388B2 (xx)
DK (1) DK2822965T3 (xx)
ES (1) ES2919861T3 (xx)
HK (1) HK1202881A1 (xx)
WO (1) WO2013132053A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2636684A1 (en) * 2012-03-09 2013-09-11 CSL Behring AG Prevention of infection
AU2013201393B2 (en) 2012-03-09 2015-08-27 Csl Behring Ag Compositions
ES2833100T3 (es) * 2013-07-01 2021-06-14 Csl Behring Ag Procedimiento
GB201413227D0 (en) 2014-07-25 2014-09-10 Bioproducts Lab Ltd Process
DE202014105749U1 (de) * 2014-11-27 2015-01-09 iCradle GmbH Daumenschalter zur Befestigung an einem Fahrradlenker und über einen derartigen Daumenschalter bedienbares Steuersystem für ein Fahrrad
CN108779166A (zh) * 2015-10-21 2018-11-09 科博锐恩生物制品有限责任公司 从血浆纯化蛋白质的方法
WO2018115048A1 (en) 2016-12-20 2018-06-28 Csl Behring Ag Methods for affecting salmonella infections
CN111278862A (zh) 2017-09-21 2020-06-12 Umc乌德勒支控股有限公司 用于治疗成神经细胞瘤的抗gd2抗体
SG11202008734WA (en) * 2018-05-17 2020-10-29 Csl Behring Ag Method and system of protein extraction
MX2021006212A (es) 2018-11-30 2021-08-11 Csl Behring Ag Metodos y composiciones para prevenir o tratar exacerbaciones agudas con inmunoglobulina policlonal.
CA3131705A1 (en) 2019-03-27 2020-10-01 Umc Utrecht Holding B.V. Engineered iga antibodies and methods of use
CN112574296B (zh) * 2020-12-30 2023-05-19 中国医学科学院输血研究所 一种模拟IVIg的多人份混合人血浆IgG样品的分离纯化方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5500345A (en) * 1989-04-25 1996-03-19 Iatron Laboratories, Inc. Hybridomas producing monoclonal antibodies specific for C-reactive protein and methods for detection of C-reactive protein
DE3927111C3 (de) 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
US5258177A (en) * 1991-12-10 1993-11-02 Alpha Therapeutic Corporation IgA preparation and process of making the same
FR2706466B1 (fr) 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
JP3504661B2 (ja) 1993-07-30 2004-03-08 オラヴァックス インク 呼吸器合胞体ウイルスに対するモノクローナルＩｇＡ抗体
DE19600939C1 (de) 1996-01-12 1997-08-28 Immuno Ag Verfahren zur Trennung von IgG und IgA
EP0839915A1 (en) 1996-11-01 1998-05-06 Institut Suisse De Recherches Experimentales Sur Le Cancer Isrec Secretory immunoglobulin A as a mucosal vaccine delivery system
AU8063798A (en) 1997-06-19 1999-01-04 Regents Of The University Of California, The Secretory immunoglobulin produced by single cells and methods for making and using same
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
US20020114802A1 (en) 1998-02-10 2002-08-22 Tjellstrom Bo Arthur Einar Oral immunoglobulin treatment for inflammatory bowel disease
AU753468B2 (en) 1998-06-09 2002-10-17 Csl Behring Ag Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
JP2000103800A (ja) 1998-09-29 2000-04-11 Yoshitomi Pharmaceut Ind Ltd 免疫グロブリンａの精製方法
AUPP806999A0 (en) * 1999-01-08 1999-02-04 Csl Limited Process for purifying immunoglobulins
EP1068871A1 (en) 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
DE60036132T2 (de) 1999-12-13 2008-08-21 Universidad Nacional Autonoma De Mexico Quantitative immunoenzymatische messmethode
CA2437814C (en) 2001-02-12 2008-05-13 Medarex, Inc. Human monoclonal antibodies to fc alpha receptor (cd89)
US6932967B2 (en) 2001-03-22 2005-08-23 Michael R. Simon Human medical treatment by aerosol inhalation of immunoglobulin A
FR2824568B1 (fr) 2001-05-11 2004-04-09 Lab Francais Du Fractionnement Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
US20060165675A1 (en) 2002-08-02 2006-07-27 Richman-Eisenstat Janice Beth Modulation of mesenchymal cells via iga-receptors
WO2005047334A1 (en) 2003-11-13 2005-05-26 Hanmi Pharmaceutical. Co., Ltd. Igg fc fragment for a drug carrier and method for the preparation thereof
US8313730B2 (en) 2006-12-13 2012-11-20 Michael R. Simon Treatment of celiac disease with IgA
US7597891B2 (en) 2006-12-13 2009-10-06 Simon Michael R Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases
US20080145420A1 (en) 2006-12-13 2008-06-19 Simon Michael R HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES
US8021645B2 (en) 2006-12-13 2011-09-20 Simon Michael R Synthesis of human secretory IgA and IgM and the formation of a medicament therefrom
US8709413B2 (en) 2006-12-13 2014-04-29 Michael R. Simon Treatment of celiac disease with IgA
US8119104B2 (en) 2006-12-13 2012-02-21 Michael R. Simon Treatment of celiac disease with IgA
US7794721B2 (en) 2006-12-13 2010-09-14 Simon Michael R Synthesis of human secretory IgM and the treatment of clostridium difficile associated diseases herewith
CA2734139C (en) 2007-10-02 2019-12-24 Avaxia Biologics, Inc. Antibody therapy for use in the digestive tract
KR101645957B1 (ko) 2008-05-15 2016-08-05 더블유. 헬스 엘.피. 분비 면역글로블린이 풍부한 우유 분획 제조방법
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
EP2465536A1 (en) 2010-12-14 2012-06-20 CSL Behring AG CD89 activation in therapy
CN104136121B (zh) * 2012-02-14 2017-04-19 生物辐射实验室股份有限公司 减少离子交换色谱中的pH漂移
AU2013201393B2 (en) 2012-03-09 2015-08-27 Csl Behring Ag Compositions
EP2636683A1 (en) 2012-03-09 2013-09-11 CSL Behring AG Treatment of mucositis with Immunoglobulin
EP2636684A1 (en) 2012-03-09 2013-09-11 CSL Behring AG Prevention of infection
WO2013158279A1 (en) * 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species

Also Published As

Publication number Publication date
JP2015509523A (ja) 2015-03-30
EP2822965A1 (en) 2015-01-14
CN104245728A (zh) 2014-12-24
AU2013201388A1 (en) 2013-09-26
US20150005476A1 (en) 2015-01-01
EP2636681A1 (en) 2013-09-11
KR20140136028A (ko) 2014-11-27
US9828418B2 (en) 2017-11-28
WO2013132053A1 (en) 2013-09-12
CN104245728B (zh) 2017-11-28
EP2822965B1 (en) 2022-05-11
AU2013201388B2 (en) 2015-09-03
KR102079487B1 (ko) 2020-02-21
ES2919861T3 (es) 2022-07-28
DK2822965T3 (da) 2022-07-11
JP6259777B2 (ja) 2018-01-10

Similar Documents

Publication Publication Date Title
IL235826A (en) Diazaspirocycloalkanes and thenaspirocycloalkanes and their preparation
ZA201500603B (en) Process
HK1202881A1 (en) Process for enriching iga iga
GB201216921D0 (en) Process
ZA201405746B (en) Rafamycin analogs and methods for making same
GB201207997D0 (en) Process
GB201214326D0 (en) Process
SG11201500381TA (en) Process
EP2837619A4 (en) PROCESS FOR THE PRODUCTION OF BETA-ALCOXYPROPIONAMIDE
IL236450A0 (en) Process for the preparation of 5-fluoro-h1-pyrazoles
PL399418A1 (pl) Sposób wytwarzania 4-metoksydihydrochalkonu
EP2852660A4 (en) PROCESS
EP2824130A4 (en) PROCESS FOR PRODUCING POLYDIALKYLSILANE
GB201219224D0 (en) Process
ZA201502344B (en) Process
GB201318062D0 (en) Process
EP2883960A4 (en) PROCESS FOR PRODUCING GLUTAMYL-VALYL-GLYCINE CRYSTAL
SG11201501567QA (en) Method for producing 7-octenal
GB201317561D0 (en) Process
IL234526A (en) METHOD FOR PRODUCING DIETHINE TETRACARBOXIMIDES
GB201316604D0 (en) Process
HUP1200614A2 (en) Process for development catalayzer
HK1206043A1 (en) Process
GB201223071D0 (en) Process
GB201222686D0 (en) Process